{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:17:35Z","timestamp":1791919055704,"version":"4.3.4"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T00:00:00Z","timestamp":1637366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T00:00:00Z","timestamp":1637366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s11064-021-03488-7","type":"journal-article","created":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T09:02:32Z","timestamp":1637398952000},"page":"552-573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders"],"prefix":"10.1007","volume":"47","author":[{"given":"Thuy Trang","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Thuy Dung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen-Minh-An","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9937-7865","authenticated-orcid":false,"given":"Giau","family":"Van Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,20]]},"reference":[{"issue":"2","key":"3488_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s13273-015-0011-9","volume":"11","author":"V Van Giau","year":"2015","unstructured":"Van Giau V, An SSA, Bagyinszky E, Kim S (2015) Gene panels and primers for next generation sequencing studies on neurodegenerative disorders. Mol Cell Toxicol 11(2):89\u2013143","journal-title":"Mol Cell Toxicol"},{"key":"3488_CR2","doi-asserted-by":"crossref","unstructured":"TT Nguyen, TTD Nguyen, TKO Nguyen, TK Vo, VG Vo (2021) Advances in developing therapeutic strategies for Alzheimer\u2019s disease. Biomed Pharmacoth 139: 111623.","DOI":"10.1016\/j.biopha.2021.111623"},{"issue":"4","key":"3488_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2147\/NDT.S2006","volume":"4","author":"J Jankovic","year":"2008","unstructured":"Jankovic J, Aguilar LG (2008) Current approaches to the treatment of Parkinson\u2019s disease. Neuropsychiatr Dis Treat 4(4):743\u2013757","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"3488_CR4","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1172\/JCI24761","volume":"115","author":"L Bertram","year":"2005","unstructured":"Bertram L, Tanzi RE (2005) The genetic epidemiology of neurodegenerative disease. J Clin Invest 115(6):1449\u20131457","journal-title":"J Clin Invest"},{"issue":"5","key":"3488_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3109\/09687688.2014.937468","volume":"31","author":"M Tajes","year":"2014","unstructured":"Tajes M, Ramos-Fern\u00e1ndez E, Weng-Jiang X, Bosch-Morat\u00f3 M, Guivernau B, Eraso-Pichot A, Salvador B, Fern\u00e0ndez-Busquets X, Roquer J, Mu\u00f1oz FJ (2014) The blood-brain barrier: structure, function and therapeutic approaches to cross it. Mol Membr Biol 31(5):152\u2013167","journal-title":"Mol Membr Biol"},{"issue":"5","key":"3488_CR6","doi-asserted-by":"publisher","first-page":"1900159","DOI":"10.1002\/adtp.201900159","volume":"3","author":"L Feng","year":"2020","unstructured":"Feng L, Wang H, Xue X (2020) Recent progress of nanomedicine in the treatment of central nervous system diseases. Adv Therape 3(5):1900159","journal-title":"Adv Therape"},{"key":"3488_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jns.2018.09.033","volume":"395","author":"V Van Giau","year":"2018","unstructured":"Van Giau V, An SSA, Hulme JP (2018) Mitochondrial therapeutic interventions in Alzheimer\u2019s disease. J Neurol Sci 395:62\u201370","journal-title":"J Neurol Sci"},{"key":"3488_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-3-030-55035-6_13","volume":"1286","author":"TT Nguyen","year":"2021","unstructured":"Nguyen TT, Vo TK, Vo GV (2021) Therapeutic strategies and nano-drug delivery applications in management of aging Alzheimer\u2019s disease. Adv Exp Med Biol 1286:183\u2013198","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"3488_CR9","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1021\/acs.nanolett.9b04683","volume":"20","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zou Y, Feng C, Lee A, Yin J, Chung R, Park JB, Rizos H, Tao W, Zheng M, Farokhzad OC, Shi B (2020) Charge conversional biomimetic nanocomplexes as a multifunctional platform for boosting orthotopic glioblastoma RNAi therapy. Nano Lett 20(3):1637\u20131646","journal-title":"Nano Lett"},{"issue":"7","key":"3488_CR10","doi-asserted-by":"publisher","first-page":"1800053","DOI":"10.1002\/adtp.201800053","volume":"1","author":"T Lang","year":"2018","unstructured":"Lang T, Yin Q, Li Y (2018) Progress of cell-derived biomimetic drug delivery systems for cancer therapy. Adv Therap 1(7):1800053","journal-title":"Adv Therap"},{"issue":"2","key":"3488_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JAD-2008-15213","volume":"15","author":"RE Becker","year":"2008","unstructured":"Becker RE, Greig NH, Giacobini E (2008) Why do so many drugs for Alzheimer\u2019s disease fail in development? time for new methods and new practices? J Alzheimers Dis 15(2):303\u2013325","journal-title":"J Alzheimers Dis"},{"key":"3488_CR12","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.2147\/NDT.S84266","volume":"11","author":"VV Giau","year":"2015","unstructured":"Giau VV, Bagyinszky E, An SSA, Kim SY (2015) Role of apolipoprotein E in neurodegenerative diseases. Neuropsychiatr Dis Treat 11:1723\u20131737","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"11","key":"3488_CR13","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nrd938","volume":"1","author":"MS Wolfe","year":"2002","unstructured":"Wolfe MS (2002) Therapeutic strategies for Alzheimer\u2019s disease. Nat Rev Drug Discov 1(11):859\u2013866","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"3488_CR14","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1(1):a006189","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3488_CR15","doi-asserted-by":"publisher","first-page":"672594","DOI":"10.3389\/fbioe.2021.672594","volume":"9","author":"A Li","year":"2021","unstructured":"Li A, Tyson J, Patel S, Patel M, Katakam S, Mao X, He W (2021) Emerging nanotechnology for treatment of Alzheimer\u2019s and Parkinson\u2019s disease. Front Bioeng Biotechnol 9:672594\u2013672594","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"3488_CR16","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag A-E, Lang AE (2017) Parkinson disease. Nat Rev Dis Primers 3(1):17013","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"3488_CR17","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) \u03b1-synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2(2):a009399","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"3488_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-011-0839-6","volume":"122","author":"KA Josephs","year":"2011","unstructured":"Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM, Dickson DW (2011) Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol 122(2):137\u2013153","journal-title":"Acta Neuropathol"},{"issue":"10","key":"3488_CR19","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1001\/archneur.64.10.1388","volume":"64","author":"M Neumann","year":"2007","unstructured":"Neumann M, Kwong LK, Sampathu DM, Trojanowski JQ, Lee VM (2007) TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. Arch Neurol 64(10):1388\u20131394","journal-title":"Arch Neurol"},{"issue":"2","key":"3488_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s13273-018-0015-3","volume":"14","author":"VV Giau","year":"2018","unstructured":"Giau VV, Bagyinszky E, An SSA, Kim S (2018) Clinical genetic strategies for early onset neurodegenerative diseases. Mol Cell Toxicol 14(2):123\u2013142","journal-title":"Mol Cell Toxicol"},{"issue":"17","key":"3488_CR21","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.3390\/ijms20174298","volume":"20","author":"VV Giau","year":"2019","unstructured":"Giau VV, Bagyinszky E, Youn YC, An SSA, Kim SY (2019) Genetic factors of cerebral small vessel disease and their potential clinical outcome. Int J Mol Sci 20(17):4298","journal-title":"Int J Mol Sci"},{"key":"3488_CR22","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.2147\/NDT.S165445","volume":"14","author":"E Bagyinszky","year":"2018","unstructured":"Bagyinszky E, Giau VV, Youn YC, An SSA, Kim S (2018) Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases. Neuropsychiatr Dis Treat 14:2067\u20132085","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"3488_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","volume":"5","author":"T Klockgether","year":"2019","unstructured":"Klockgether T, Mariotti C, Paulson HL (2019) Spinocerebellar ataxia. Nat Rev Dis Primers 5(1):24","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"3488_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000358801","volume":"42","author":"L Ruano","year":"2014","unstructured":"Ruano L, Melo C, Silva MC, Coutinho P (2014) The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology 42(3):174\u2013183","journal-title":"Neuroepidemiology"},{"issue":"4","key":"3488_CR25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3233\/JAD-2011-110368","volume":"24","author":"AM Palmer","year":"2011","unstructured":"Palmer AM (2011) The role of the blood brain barrier in neurodegenerative disorders and their treatment. J Alzheimers Dis 24(4):643\u2013656","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"3488_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 37(1):13\u201325","journal-title":"Neurobiol Dis"},{"issue":"21","key":"3488_CR27","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.2174\/0929867328666201218121728","volume":"28","author":"P Zamani","year":"2021","unstructured":"Zamani P, Penson PE, Barreto GE, Sahebkar A (2021) Recent advancements in liposome-based strategies for effective drug delivery to the brain. Curr Med Chem 28(21):4152\u20134171","journal-title":"Curr Med Chem"},{"key":"3488_CR28","doi-asserted-by":"publisher","first-page":"112117","DOI":"10.1016\/j.biopha.2021.112117","volume":"143","author":"TT Nguyen","year":"2021","unstructured":"Nguyen TT, Dung Nguyen TT, Vo TK, Tran N-M-A, Nguyen MK, Van Vo T, Van Vo G (2021) Nanotechnology-based drug delivery for central nervous system disorders. Biomed Pharmacotherap 143:112117","journal-title":"Biomed Pharmacotherap"},{"issue":"4","key":"3488_CR29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","volume":"2","author":"H Pajouhesh","year":"2005","unstructured":"Pajouhesh H, Lenz GR (2005) Medicinal chemical properties of successful central nervous system drugs. NeuroRx 2(4):541\u2013553","journal-title":"NeuroRx"},{"key":"3488_CR30","doi-asserted-by":"publisher","first-page":"119491","DOI":"10.1016\/j.biomaterials.2019.119491","volume":"224","author":"J Xie","year":"2019","unstructured":"Xie J, Shen Z, Anraku Y, Kataoka K, Chen X (2019) Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. Biomaterials 224:119491","journal-title":"Biomaterials"},{"key":"3488_CR31","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.2147\/IJN.S61288","volume":"9","author":"C-T Lu","year":"2014","unstructured":"Lu C-T, Zhao Y-Z, Wong HL, Cai J, Peng L, Tian X-Q (2014) Current approaches to enhance CNS delivery of drugs across the brain barriers. Int J Nanomed 9:2241\u20132257","journal-title":"Int J Nanomed"},{"issue":"2","key":"3488_CR32","first-page":"252","volume":"6","author":"A Misra","year":"2003","unstructured":"Misra A, Ganesh S, Shahiwala A, Shah SP (2003) Drug delivery to the central nervous system: a review. J Pharm Pharm Sci 6(2):252\u2013273","journal-title":"J Pharm Pharm Sci"},{"issue":"2","key":"3488_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jconrel.2012.04.044","volume":"164","author":"S Krol","year":"2012","unstructured":"Krol S (2012) Challenges in drug delivery to the brain: nature is against us. J Control Release 164(2):145\u2013155","journal-title":"J Control Release"},{"issue":"1","key":"3488_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/187221109787158355","volume":"3","author":"SA Pathan","year":"2009","unstructured":"Pathan SA, Iqbal Z, Zaidi SM, Talegaonkar S, Vohra D, Jain GK, Azeem A, Jain N, Lalani JR, Khar RK, Ahmad FJ (2009) CNS drug delivery systems: novel approaches. Recent Pat Drug Delivery Formulation 3(1):71\u201389","journal-title":"Recent Pat Drug Delivery Formulation"},{"issue":"12","key":"3488_CR35","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1166\/jbn.2016.2313","volume":"12","author":"O Gartziandia","year":"2016","unstructured":"Gartziandia O, Herr\u00e1n E, Ruiz-Ortega JA, Miguelez C, Igartua M, Lafuente JV, Pedraz JL, Ugedo L, Hern\u00e1ndez RM (2016) Intranasal administration of chitosan-coated nanostructured lipid carriers loaded with GDNF improves behavioral and histological recovery in a partial lesion model of Parkinson\u2019s disease. J Biomed Nanotechnol 12(12):2220\u20132230","journal-title":"J Biomed Nanotechnol"},{"issue":"2","key":"3488_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2174\/1567201053586047","volume":"2","author":"TK Vyas","year":"2005","unstructured":"Vyas TK, Shahiwala A, Marathe S, Misra A (2005) Intranasal drug delivery for brain targeting. Curr Drug Deliv 2(2):165\u2013175","journal-title":"Curr Drug Deliv"},{"key":"3488_CR37","doi-asserted-by":"crossref","unstructured":"NR Hussein, HK Omer, AMA Elhissi, W Ahmed (2020) Chapter 15 - advances in nasal drug delivery systems. In W Ahmed, DA Phoenix, MJ Jackson, CP Charalambous (Eds), Advances in medical and surgical engineering. Academic Press, pp 279\u2013311.","DOI":"10.1016\/B978-0-12-819712-7.00015-2"},{"issue":"1","key":"3488_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","volume":"11","author":"L Illum","year":"2000","unstructured":"Illum L (2000) Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11(1):1\u201318","journal-title":"Eur J Pharm Sci"},{"issue":"1\u20133","key":"3488_CR39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","volume":"87","author":"L Illum","year":"2003","unstructured":"Illum L (2003) Nasal drug delivery\u2013possibilities, problems and solutions. J Control Release 87(1\u20133):187\u2013198","journal-title":"J Control Release"},{"issue":"1\u20132","key":"3488_CR40","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/0006-8993(95)00637-6","volume":"692","author":"RG Thorne","year":"1995","unstructured":"Thorne RG, Emory CR, Ala TA, Frey WH 2nd (1995) Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Res 692(1\u20132):278\u2013282","journal-title":"Brain Res"},{"key":"3488_CR41","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ejps.2016.05.012","volume":"92","author":"E Muntimadugu","year":"2016","unstructured":"Muntimadugu E, Dhommati R, Jain A, Challa VG, Shaheen M, Khan W (2016) Intranasal delivery of nanoparticle encapsulated tarenflurbil: a potential brain targeting strategy for Alzheimer\u2019s disease. Eur J Pharm Sci 92:224\u2013234","journal-title":"Eur J Pharm Sci"},{"key":"3488_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.schres.2016.11.027","volume":"184","author":"YK Katare","year":"2017","unstructured":"Katare YK, Piazza JE, Bhandari J, Daya RP, Akilan K, Simpson MJ, Hoare T, Mishra RK (2017) Intranasal delivery of antipsychotic drugs. Schizophr Res 184:2\u201313","journal-title":"Schizophr Res"},{"key":"3488_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jconrel.2018.12.049","volume":"295","author":"C Costa","year":"2019","unstructured":"Costa C, Moreira JN, Amaral MH, Sousa Lobo JM, Silva AC (2019) Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis. J Control Release 295:187\u2013200","journal-title":"J Control Release"},{"issue":"1","key":"3488_CR44","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1124\/jpet.108.145565","volume":"328","author":"SV Dhuria","year":"2009","unstructured":"Dhuria SV, Hanson LR, Frey WH 2nd (2009) Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system. J Pharmacol Exp Ther 328(1):312\u2013320","journal-title":"J Pharmacol Exp Ther"},{"key":"3488_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","volume":"281","author":"M Agrawal","year":"2018","unstructured":"Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Chougule MB, Shoyele SA, Alexander A (2018) Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Control Release 281:139\u2013177","journal-title":"J Control Release"},{"issue":"4","key":"3488_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4103\/2231-4040.90876","volume":"2","author":"M Chaturvedi","year":"2011","unstructured":"Chaturvedi M, Kumar M, Pathak K (2011) A review on mucoadhesive polymer used in nasal drug delivery system. J Adv Pharm Technol Res 2(4):215\u2013222","journal-title":"J Adv Pharm Technol Res"},{"key":"3488_CR47","doi-asserted-by":"crossref","unstructured":"A Thakur, C Foged (2020) Nanoparticles for mucosal vaccine delivery. Nanoeng Biomater Adv Drug Delivery, 603\u2013646.","DOI":"10.1016\/B978-0-08-102985-5.00025-5"},{"key":"3488_CR48","doi-asserted-by":"crossref","unstructured":"L-A Keller, O Merkel, A Popp (2021) Intranasal drug delivery: opportunities and toxicologic challenges during drug development. Drug Delivery Trans Res.","DOI":"10.1007\/s13346-020-00891-5"},{"issue":"4","key":"3488_CR49","doi-asserted-by":"publisher","first-page":"e61694","DOI":"10.1371\/journal.pone.0061694","volume":"8","author":"BS Bleier","year":"2013","unstructured":"Bleier BS, Kohman RE, Feldman RE, Ramanlal S, Han X (2013) Permeabilization of the blood-brain barrier via mucosal engrafting: implications for drug delivery to the brain. PLoS One 8(4):e61694","journal-title":"PLoS One"},{"key":"3488_CR50","doi-asserted-by":"publisher","first-page":"120994","DOI":"10.1016\/j.ijpharm.2021.120994","volume":"607","author":"F Laffleur","year":"2021","unstructured":"Laffleur F, Bauer B (2021) Progress in nasal drug delivery systems. Int J Pharm 607:120994","journal-title":"Int J Pharm"},{"issue":"5","key":"3488_CR51","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3390\/molecules13051035","volume":"13","author":"B Pavan","year":"2008","unstructured":"Pavan B, Dalpiaz A, Ciliberti N, Biondi C, Manfredini S, Vertuani S (2008) Progress in drug delivery to the central nervous system by the prodrug approach. Molecules 13(5):1035\u20131065","journal-title":"Molecules"},{"issue":"1","key":"3488_CR52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0939-6411(01)00149-7","volume":"52","author":"M Miyamoto","year":"2001","unstructured":"Miyamoto M, Natsume H, Iwata S, Ohtake K, Yamaguchi M, Kobayashi D, Sugibayashi K, Yamashina M, Morimoto Y (2001) Improved nasal absorption of drugs using poly-L-arginine: effects of concentration and molecular weight of poly-L-arginine on the nasal absorption of fluorescein isothiocyanate-dextran in rats. Eur J Pharm Biopharm 52(1):21\u201330","journal-title":"Eur J Pharm Biopharm"},{"issue":"1\u20132","key":"3488_CR53","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ijpharm.2006.02.031","volume":"316","author":"F Cui","year":"2006","unstructured":"Cui F, Qian F, Yin C (2006) Preparation and characterization of mucoadhesive polymer-coated nanoparticles. Int J Pharm 316(1\u20132):154\u2013161","journal-title":"Int J Pharm"},{"issue":"5","key":"3488_CR54","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1773-2247(06)50061-9","volume":"16","author":"C Prego","year":"2006","unstructured":"Prego C, Torres D, Alonso MJ (2006) Chitosan nanocapsules: a new carrier for nasal peptide delivery. J Drug Delivery Sci Technol 16(5):331\u2013337","journal-title":"J Drug Delivery Sci Technol"},{"issue":"8","key":"3488_CR55","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1166\/jbn.2015.2078","volume":"11","author":"FN Fonseca","year":"2015","unstructured":"Fonseca FN, Betti AH, Carvalho FC, Gremi\u00e3o MP, Dimer FA, Guterres SS, Tebaldi ML, Rates SM, Pohlmann AR (2015) Mucoadhesive amphiphilic methacrylic copolymer-functionalized poly(\u03b5-caprolactone) nanocapsules for nose-to-brain delivery of olanzapine. J Biomed Nanotechnol 11(8):1472\u20131481","journal-title":"J Biomed Nanotechnol"},{"key":"3488_CR56","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.2147\/IJN.S119033","volume":"11","author":"A Clementino","year":"2016","unstructured":"Clementino A, Batger M, Garrastazu G, Pozzoli M, Del Favero E, Rondelli V, Gutfilen B, Barboza T, Sukkar MB, Souza SAL, Cant\u00f9 L, Sonvico F (2016) The nasal delivery of nanoencapsulated statins - an approach for brain delivery. Int J Nanomed 11:6575\u20136590","journal-title":"Int J Nanomed"},{"issue":"1\u20132","key":"3488_CR57","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijpharm.2009.10.018","volume":"385","author":"CE Mora-Huertas","year":"2010","unstructured":"Mora-Huertas CE, Fessi H, Elaissari A (2010) Polymer-based nanocapsules for drug delivery. Int J Pharm 385(1\u20132):113\u2013142","journal-title":"Int J Pharm"},{"issue":"5","key":"3488_CR58","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1517\/17425247.2013.769956","volume":"10","author":"AR Pohlmann","year":"2013","unstructured":"Pohlmann AR, Fonseca FN, Paese K, Detoni CB, Coradini K, Beck RC, Guterres SS (2013) Poly(\u03f5-caprolactone) microcapsules and nanocapsules in drug delivery. Expert Opin Drug Deliv 10(5):623\u2013638","journal-title":"Expert Opin Drug Deliv"},{"issue":"6","key":"3488_CR59","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1166\/jbn.2010.1161","volume":"6","author":"RL Frozza","year":"2010","unstructured":"Frozza RL, Bernardi A, Paese K, Hoppe JB, da Silva T, Battastini AM, Pohlmann AR, Guterres SS, Salbego C (2010) Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats. J Biomed Nanotechnol 6(6):694\u2013703","journal-title":"J Biomed Nanotechnol"},{"issue":"2","key":"3488_CR60","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejpb.2012.10.019","volume":"83","author":"A Zanotto-Filho","year":"2013","unstructured":"Zanotto-Filho A, Coradini K, Braganhol E, Schr\u00f6der R, de Oliveira CM, Sim\u00f5es-Pires A, Battastini AM, Pohlmann AR, Guterres SS, Forcelini CM, Beck RC, Moreira JC (2013) Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment. Eur J Pharm Biopharm 83(2):156\u201367","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"3488_CR61","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/pharmaceutics11020086","volume":"11","author":"FA Bruinsmann","year":"2019","unstructured":"Bruinsmann FA, Pigana S, Aguirre T, Dadalt Souto G, Garrastazu Pereira G, Bianchera A, Tiozzo Fasiolo L, Colombo G, Marques M, Raffin Pohlmann A, Stanis\u00e7uaski Guterres S, Sonvico F (2019) Chitosan-coated nanoparticles: effect of chitosan molecular weight on nasal transmucosal delivery. Pharmaceutics 11(2):86","journal-title":"Pharmaceutics"},{"issue":"1","key":"3488_CR62","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","volume":"379","author":"A Mistry","year":"2009","unstructured":"Mistry A, Stolnik S, Illum L (2009) Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm 379(1):146\u2013157","journal-title":"Int J Pharm"},{"issue":"3","key":"3488_CR63","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1039\/C6NR07581A","volume":"9","author":"E Ahmad","year":"2017","unstructured":"Ahmad E, Feng Y, Qi J, Fan W, Ma Y, He H, Xia F, Dong X, Zhao W, Lu Y, Wu W (2017) Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles. Nanoscale 9(3):1174\u20131183","journal-title":"Nanoscale"},{"issue":"2","key":"3488_CR64","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jconrel.2011.08.017","volume":"161","author":"S Wohlfart","year":"2012","unstructured":"Wohlfart S, Gelperina S, Kreuter J (2012) Transport of drugs across the blood-brain barrier by nanoparticles. J Control Release 161(2):264\u2013273","journal-title":"J Control Release"},{"issue":"4","key":"3488_CR65","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1208\/s12248-015-9719-7","volume":"17","author":"ME Meredith","year":"2015","unstructured":"Meredith ME, Salameh TS, Banks WA (2015) Intranasal delivery of proteins and peptides in the treatment of neurodegenerative diseases. AAPS J 17(4):780\u2013787","journal-title":"AAPS J"},{"issue":"4","key":"3488_CR66","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/jps.21924","volume":"99","author":"SV Dhuria","year":"2010","unstructured":"Dhuria SV, Hanson LR, Frey WH 2nd (2010) Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 99(4):1654\u20131673","journal-title":"J Pharm Sci"},{"issue":"3","key":"3488_CR67","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3109\/10717544.2014.920431","volume":"23","author":"A Kumar","year":"2016","unstructured":"Kumar A, Pandey AN, Jain SK (2016) Nasal-nanotechnology: revolution for efficient therapeutics delivery. Drug Delivery 23(3):681\u2013693","journal-title":"Drug Delivery"},{"key":"3488_CR68","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.ijbiomac.2017.11.031","volume":"108","author":"SK Singh","year":"2018","unstructured":"Singh SK, Hidau MK, Gautam S, Gupta K, Singh KP, Singh SK, Singh S (2018) Glycol chitosan functionalized asenapine nanostructured lipid carriers for targeted brain delivery: pharmacokinetic and teratogenic assessment. Int J Biol Macromol 108:1092\u20131100","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"3488_CR69","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.xphs.2018.04.007","volume":"107","author":"H Abbas","year":"2018","unstructured":"Abbas H, Refai H, El Sayed N (2018) Superparamagnetic Iron oxide-loaded lipid nanocarriers incorporated in thermosensitive in situ gel for magnetic brain targeting of clonazepam. J Pharm Sci 107(8):2119\u20132127","journal-title":"J Pharm Sci"},{"key":"3488_CR70","doi-asserted-by":"publisher","first-page":"110446","DOI":"10.1016\/j.colsurfb.2019.110446","volume":"183","author":"W Du","year":"2019","unstructured":"Du W, Li H, Tian B, Sai S, Gao Y, Lan T, Meng Y, Ding C (2019) Development of nose-to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice. Colloids Surf B Biointerf 183:110446","journal-title":"Colloids Surf B Biointerf"},{"issue":"8","key":"3488_CR71","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1080\/03639045.2019.1593434","volume":"45","author":"MH Patel","year":"2019","unstructured":"Patel MH, Mundada VP, Sawant KK (2019) Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, in vitro characterization, cell line studies and in vivo efficacy in schizophrenia. Drug Dev Ind Pharm 45(8):1242\u20131257","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"3488_CR72","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1208\/s12249-018-1213-y","volume":"20","author":"DG Gadhave","year":"2019","unstructured":"Gadhave DG, Tagalpallewar AA, Kokare CR (2019) Agranulocytosis-protective olanzapine-loaded nanostructured lipid carriers engineered for CNS delivery: optimization and hematological toxicity studies. AAPS PharmSciTech 20(1):22","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"3488_CR73","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1080\/03639045.2019.1593439","volume":"45","author":"GM Jojo","year":"2019","unstructured":"Jojo GM, Kuppusamy G, De A, Karri V (2019) Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer\u2019s disease using Box-Behnken design. Drug Dev Ind Pharm 45(7):1061\u20131072","journal-title":"Drug Dev Ind Pharm"},{"key":"3488_CR74","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jddst.2019.01.040","volume":"51","author":"AP Rajput","year":"2019","unstructured":"Rajput AP, Butani SB (2019) Resveratrol anchored nanostructured lipid carrier loaded in situ gel via nasal route: formulation, optimization and in vivo characterization. J Drug Delivery Sci Technol 51:214\u2013223","journal-title":"J Drug Delivery Sci Technol"},{"issue":"5","key":"3488_CR75","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/10667857.2019.1674522","volume":"35","author":"CV Pardeshi","year":"2020","unstructured":"Pardeshi CV, Belgamwar VS (2020) Improved brain pharmacokinetics following intranasal administration of N,N, N-trimethyl chitosan tailored mucoadhesive NLCs. Mater Technol 35(5):249\u2013266","journal-title":"Mater Technol"},{"issue":"5","key":"3488_CR76","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/03639045.2019.1576724","volume":"45","author":"DG Gadhave","year":"2019","unstructured":"Gadhave DG, Kokare CR (2019) Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies. Drug Dev Ind Pharm 45(5):839\u2013851","journal-title":"Drug Dev Ind Pharm"},{"issue":"6","key":"3488_CR77","first-page":"799","volume":"3","author":"G Sandrini","year":"2007","unstructured":"Sandrini G, Perrotta A, Arce Leal NL, Buscone S, G, (2007) Nappi, Almotriptan in the treatment of migraine. Neuropsychiatr Dis Treat 3(6):799\u2013809","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"8","key":"3488_CR78","first-page":"1838","volume":"46","author":"M Yasir","year":"2018","unstructured":"Yasir M, Sara UVS, Chauhan I, Gaur PK, Singh AP, Puri D (2018) Solid lipid nanoparticles for nose to brain delivery of donepezil: formulation, optimization by Box-Behnken design, in vitro and in vivo evaluation Artificial cells. Nanomed Biotechnol 46(8):1838\u20131851","journal-title":"Nanomed Biotechnol"},{"key":"3488_CR79","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.2147\/IJN.S214657","volume":"14","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Liu C, Zhai W, Zhuang N, Han T, Ding Z (2019) The optimization design of lactoferrin loaded HupA nanoemulsion for targeted drug transport via intranasal route. Int J Nanomed 14:9217\u20139234","journal-title":"Int J Nanomed"},{"key":"3488_CR80","doi-asserted-by":"publisher","first-page":"2382563","DOI":"10.1155\/2019\/2382563","volume":"2019","author":"B Gaba","year":"2019","unstructured":"Gaba B, Khan T, Haider MF, Alam T, Baboota S, Parvez S, Ali J (2019) Vitamin E loaded naringenin nanoemulsion via intranasal delivery for the management of oxidative stress in a 6-OHDA Parkinson\u2019s disease model. Biomed Res Int 2019:2382563","journal-title":"Biomed Res Int"},{"issue":"4","key":"3488_CR81","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2174\/1570163815666180418144019","volume":"16","author":"R Rukmangathen","year":"2019","unstructured":"Rukmangathen R, Yallamalli IM, Yalavarthi PR (2019) Biopharmaceutical potential of selegiline loaded chitosan nanoparticles in the management of Parkinson\u2019s disease. Curr Drug Discov Technol 16(4):417\u2013425","journal-title":"Curr Drug Discov Technol"},{"key":"3488_CR82","doi-asserted-by":"publisher","first-page":"104917","DOI":"10.1016\/j.chemphyslip.2020.104917","volume":"230","author":"A Arora","year":"2020","unstructured":"Arora A, Kumar S, Ali J, Baboota S (2020) Intranasal delivery of tetrabenazine nanoemulsion via olfactory region for better treatment of hyperkinetic movement associated with Huntington\u2019s disease: pharmacokinetic and brain delivery study. Chem Phy Lipids 230:104917","journal-title":"Chem Phy Lipids"},{"key":"3488_CR83","doi-asserted-by":"publisher","first-page":"119486","DOI":"10.1016\/j.ijpharm.2020.119486","volume":"585","author":"RJ Patel","year":"2020","unstructured":"Patel RJ, Parikh RH (2020) Intranasal delivery of topiramate nanoemulsion: pharmacodynamic, pharmacokinetic and brain uptake studies. Int J Pharm 585:119486","journal-title":"Int J Pharm"},{"issue":"25","key":"3488_CR84","doi-asserted-by":"publisher","first-page":"6519","DOI":"10.1016\/j.biomaterials.2010.04.044","volume":"31","author":"M Gobbi","year":"2010","unstructured":"Gobbi M, Re F, Canovi M, Beeg M, Gregori M, Sesana S, Sonnino S, Brogioli D, Musicanti C, Gasco P, Salmona M, Masserini ME (2010) Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide. Biomaterials 31(25):6519\u20136529","journal-title":"Biomaterials"},{"key":"3488_CR85","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejpb.2019.12.014","volume":"148","author":"H Akel","year":"2020","unstructured":"Akel H, Ismail R, Cs\u00f3ka I (2020) Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer\u2019s disease. Euro J Pharm Biopharm 148:38\u201353","journal-title":"Euro J Pharm Biopharm"},{"key":"3488_CR86","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jconrel.2020.02.020","volume":"321","author":"M Agrawal","year":"2020","unstructured":"Agrawal M, Saraf S, Saraf S, Dubey SK, Puri A, Patel RJ, Ajazuddin V, Murthy US, Alexander A (2020) Alexander, Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting. J Controlled Release 321:372\u2013415","journal-title":"J Controlled Release"},{"issue":"3","key":"3488_CR87","doi-asserted-by":"publisher","first-page":"305","DOI":"10.15171\/apb.2015.043","volume":"5","author":"N Naseri","year":"2015","unstructured":"Naseri N, Valizadeh H, Zakeri-Milani P (2015) Solid lipid nanoparticles and nanostructured lipid carriers: structure preparation and application. Adv Pharm Bull 5(3):305\u2013313","journal-title":"Adv Pharm Bull"},{"issue":"1","key":"3488_CR88","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jconrel.2006.05.010","volume":"114","author":"Y Luo","year":"2006","unstructured":"Luo Y, Chen D, Ren L, Zhao X, Qin J (2006) Solid lipid nanoparticles for enhancing vinpocetine\u2019s oral bioavailability. J Control Release 114(1):53\u201359","journal-title":"J Control Release"},{"issue":"1","key":"3488_CR89","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.colsurfb.2011.03.035","volume":"86","author":"AC Silva","year":"2011","unstructured":"Silva AC, Gonz\u00e1lez-Mira E, Garc\u00eda ML, Egea MA, Fonseca J, Silva R, Santos D, Souto EB, Ferreira D (2011) Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound, Colloids and surfaces. B, Biointerfaces 86(1):158\u2013165","journal-title":"B, Biointerfaces"},{"issue":"2","key":"3488_CR90","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/026520499289185","volume":"16","author":"C Schwarz","year":"1999","unstructured":"Schwarz C, Mehnert W (1999) Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization. J Microencapsulation 16(2):205\u201313","journal-title":"J Microencapsulation"},{"issue":"2","key":"3488_CR91","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0939-6411(97)00150-1","volume":"45","author":"A Zur M\u00fchlen","year":"1998","unstructured":"Zur M\u00fchlen A, Schwarz C, Mehnert W (1998) Solid lipid nanoparticles (SLN) for controlled drug delivery\u2013drug release and release mechanism. Eur J Pharm Biopharm 45(2):149\u201355","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"3488_CR92","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2017018693","volume":"34","author":"S Cunha","year":"2017","unstructured":"Cunha S, Amaral MH, Lobo JMS, Silva AC (2017) Lipid nanoparticles for nasal\/intranasal drug delivery. Crit Rev Ther Drug Carrier Syst 34(3):257\u2013282","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"3488_CR93","doi-asserted-by":"publisher","first-page":"102642","DOI":"10.1016\/j.jddst.2021.102642","volume":"64","author":"NA Emad","year":"2021","unstructured":"Emad NA, Ahmed B, Alhalmi A, Alzobaidi N, Al-Kubati SS (2021) Recent progress in nanocarriers for direct nose to brain drug delivery. J Drug Deliv Sci Technol 64:102642","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1\u20132","key":"3488_CR94","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ijpharm.2013.05.009","volume":"452","author":"ZZ Yang","year":"2013","unstructured":"Yang ZZ, Zhang YQ, Wang ZZ, Wu K, Lou JN, Qi XR (2013) Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration. Int J Pharm 452(1\u20132):344\u2013354","journal-title":"Int J Pharm"},{"issue":"2","key":"3488_CR95","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.etap.2012.04.012","volume":"34","author":"W Li","year":"2012","unstructured":"Li W, Zhou Y, Zhao N, Hao B, Wang X, Kong P (2012) Pharmacokinetic behavior and efficiency of acetylcholinesterase inhibition in rat brain after intranasal administration of galanthamine hydrobromide loaded flexible liposomes. Environ Toxicol Pharmacol 34(2):272\u2013279","journal-title":"Environ Toxicol Pharmacol"},{"key":"3488_CR96","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejps.2015.07.002","volume":"78","author":"B Shah","year":"2015","unstructured":"Shah B, Khunt D, Bhatt H, Misra M, Padh H (2015) Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: effect on formulation and characterization parameters. Eur J pharm Sci 78:54\u201366","journal-title":"Eur J pharm Sci"},{"key":"3488_CR97","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.colsurfb.2017.01.031","volume":"152","author":"G Rassu","year":"2017","unstructured":"Rassu G, Soddu E, Posadino AM, Pintus G, Sarmento B, Giunchedi P, Gavini E (2017) Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer\u2019s therapy. Colloid Surf B Biointerf 152:296\u2013301","journal-title":"Colloid Surf B Biointerf"},{"issue":"1","key":"3488_CR98","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/157341309787314656","volume":"5","author":"ML Bondi","year":"2009","unstructured":"Bondi ML, Montana G, Craparo EF, Picone P, Capuano G, Carlo MD, Giammona G (2009) Ferulic acid-loaded lipid nanostructures as drug delivery systems for Alzheimers disease: preparation characterization and cytotoxicity studies. Curr Nanosci 5(1):26\u201332","journal-title":"Curr Nanosci"},{"issue":"3","key":"3488_CR99","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0939-6411(02)00083-8","volume":"54","author":"JX Wang","year":"2002","unstructured":"Wang JX, Sun X, Zhang ZR (2002) Enhanced brain targeting by synthesis of 3\u2019,5\u2019-dioctanoyl-5-fluoro-2\u2019-deoxyuridine and incorporation into solid lipid nanoparticles. Eur J Pharm Biopharm 54(3):285\u201390","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"3488_CR100","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3109\/1061186X.2012.747529","volume":"21","author":"M Yusuf","year":"2013","unstructured":"Yusuf M, Khan M, Khan RA, Ahmed B (2013) Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer\u2019s disease model. J Drug Target 21(3):300\u2013311","journal-title":"J Drug Target"},{"key":"3488_CR101","doi-asserted-by":"publisher","first-page":"P299","DOI":"10.1016\/j.jalz.2013.05.609","volume":"9","author":"S Sood","year":"2013","unstructured":"Sood S, Jain K, Gowthamarajan K (2013) P1\u2013382: curcumin-donepezil\u2013loaded nanostructured lipid carriers for intranasal delivery in an Alzheimer\u2019s disease model. Alzheimer\u2019s Dementia 9:P299","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"1\u20132","key":"3488_CR102","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijpharm.2010.05.005","volume":"394","author":"CY Zhuang","year":"2010","unstructured":"Zhuang CY, Li N, Wang M, Zhang XN, Pan WS, Peng JJ, Pan YS, Tang X (2010) Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm 394(1\u20132):179\u2013185","journal-title":"Int J Pharm"},{"issue":"3","key":"3488_CR103","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1166\/jbn.2013.1547","volume":"9","author":"F Figueir\u00f3","year":"2013","unstructured":"Figueir\u00f3 F, Bernardi A, Frozza RL, Terroso T, Zanotto-Filho A, Jandrey EH, Moreira JC, Salbego CG, Edelweiss MI, Pohlmann AR, Guterres SS, Battastini AM (2013) Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth. J Biomed Nanotechnol 9(3):516\u2013526","journal-title":"J Biomed Nanotechnol"},{"issue":"2","key":"3488_CR104","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/jps.22285","volume":"100","author":"MJ Tsai","year":"2011","unstructured":"Tsai MJ, Huang YB, Wu PC, Fu YS, Kao YR, Fang JY, Tsai YH (2011) Oral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: pharmacokinetic and behavioral evaluations. J Pharm Sci 100(2):547\u2013557","journal-title":"J Pharm Sci"},{"issue":"9","key":"3488_CR105","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s10856-013-4965-7","volume":"24","author":"CV Pardeshi","year":"2013","unstructured":"Pardeshi CV, Belgamwar VS, Tekade AR, Surana SJ (2013) Novel surface modified polymer-lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation. J Mater Sci Mater Med 24(9):2101\u20132115","journal-title":"J Mater Sci Mater Med"},{"issue":"7","key":"3488_CR106","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s11095-007-9514-y","volume":"25","author":"E Esposito","year":"2008","unstructured":"Esposito E, Fantin M, Marti M, Drechsler M, Paccamiccio L, Mariani P, Sivieri E, Lain F, Menegatti E, Morari M, Cortesi R (2008) Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm Res 25(7):1521\u20131530","journal-title":"Pharm Res"},{"key":"3488_CR107","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.2147\/IJN.S261855","volume":"15","author":"KM Hosny","year":"2020","unstructured":"Hosny KM (2020) Nanosized cubosomal thermogelling dispersion loaded with saquinavir mesylate to improve its bioavailability: preparation, optimization, in vitro and in vivo evaluation. Int J Nanomed 15:5113\u20135129","journal-title":"Int J Nanomed"},{"issue":"12","key":"3488_CR108","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1021\/acschemneuro.6b00207","volume":"7","author":"P Kundu","year":"2016","unstructured":"Kundu P, Das M, Tripathy K, Sahoo SK (2016) Delivery of dual drug loaded lipid based nanoparticles across the blood-brain barrier impart enhanced neuroprotection in a rotenone induced mouse model of Parkinson\u2019s disease. ACS Chem Neurosci 7(12):1658\u20131670","journal-title":"ACS Chem Neurosci"},{"issue":"4","key":"3488_CR109","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.nano.2013.10.009","volume":"10","author":"YZ Zhao","year":"2014","unstructured":"Zhao YZ, Li X, Lu CT, Lin M, Chen LJ, Xiang Q, Zhang M, Jin RR, Jiang X, Shen XT, Li XK, Cai J (2014) Gelatin nanostructured lipid carriers-mediated intranasal delivery of basic fibroblast growth factor enhances functional recovery in hemiparkinsonian rats. Nanomed Nanotechnol Biol Med 10(4):755\u2013764","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"3488_CR110","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.lfs.2017.11.046","volume":"193","author":"P Hassanzadeh","year":"2018","unstructured":"Hassanzadeh P, Arbabi E, Atyabi F, Dinarvand R (2018) Ferulic acid-loaded nanostructured lipid carriers: a promising nanoformulation against the ischemic neural injuries. Life Sci 193:64\u201376","journal-title":"Life Sci"},{"issue":"9","key":"3488_CR111","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1080\/10717544.2016.1223218","volume":"23","author":"S Zhang","year":"2016","unstructured":"Zhang S, Wang J, Pan J (2016) Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats. Drug Delivery 23(9):3696\u20133703","journal-title":"Drug Delivery"},{"issue":"12","key":"3488_CR112","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1016\/j.xphs.2017.08.024","volume":"106","author":"P Wavikar","year":"2017","unstructured":"Wavikar P, Pai R, Vavia P (2017) Nose to brain delivery of rivastigmine by in situ gelling cationic nanostructured lipid carriers: enhanced brain distribution and pharmacodynamics. J Pharm Sci 106(12):3613\u20133622","journal-title":"J Pharm Sci"},{"issue":"1","key":"3488_CR113","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.biomaterials.2013.09.093","volume":"35","author":"Y-M Lu","year":"2014","unstructured":"Lu Y-M, Huang J-Y, Wang H, Lou X-F, Liao M-H, Hong L-J, Tao R-R, Ahmed MM, Shan C-L, Wang X-L, Fukunaga K, Du Y-Z, Han F (2014) Targeted therapy of brain ischaemia using fas ligand antibody conjugated PEG-lipid nanoparticles. Biomaterials 35(1):530\u2013537","journal-title":"Biomaterials"},{"issue":"1","key":"3488_CR114","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1080\/10717544.2017.1337825","volume":"24","author":"A Parikh","year":"2017","unstructured":"Parikh A, Kathawala K, Tan CC, Garg S, Zhou XF (2017) Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro\/in vivo evaluation. Drug Delivery 24(1):962\u2013978","journal-title":"Drug Delivery"},{"issue":"30","key":"3488_CR115","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1016\/j.biomaterials.2008.07.008","volume":"29","author":"Y Gao","year":"2008","unstructured":"Gao Y, Gu W, Chen L, Xu Z, Li Y (2008) The role of daidzein-loaded sterically stabilized solid lipid nanoparticles in therapy for cardio-cerebrovascular diseases. Biomaterials 29(30):4129\u20134136","journal-title":"Biomaterials"},{"issue":"3","key":"3488_CR116","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3109\/10837450.2012.734513","volume":"18","author":"NM Morsi","year":"2013","unstructured":"Morsi NM, Ghorab DM, Badie HA (2013) Brain targeted solid lipid nanoparticles for brain ischemia: preparation and in vitro characterization. Pharm Dev Technol 18(3):736\u2013744","journal-title":"Pharm Dev Technol"},{"key":"3488_CR117","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ejpb.2013.02.005","volume":"85","author":"V Kakkar","year":"2013","unstructured":"Kakkar V, Muppu SK, Chopra K, Kaur IP (2013) Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats. Eur J Pharm Biopharm 85:339\u201345","journal-title":"Eur J Pharm Biopharm"},{"key":"3488_CR118","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.colsurfb.2018.03.052","volume":"167","author":"S Scioli Montoto","year":"2018","unstructured":"Scioli Montoto S, Sbaraglini ML, Talevi A, Couyoupetrou M, Di Ianni M, Pesce GO, Alvarez VA, Bruno-Blanch LE, Castro GR, Ruiz ME, Islan GA (2018) Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: physicochemical characterization and in vitro\/in vivo evaluation. Colloids Surf B Biointerf 167:73\u201381","journal-title":"Colloids Surf B Biointerf"},{"key":"3488_CR119","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1476-511X-11-72","volume":"11","author":"R Nair","year":"2012","unstructured":"Nair R, Kumar AC, Priya VK, Yadav CM, Raju PY (2012) Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine. Lipids Health Dis 11:72","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3488_CR120","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1208\/s12249-009-9197-2","volume":"10","author":"G Abdelbary","year":"2009","unstructured":"Abdelbary G, Fahmy RH (2009) Diazepam-loaded solid lipid nanoparticles: design and characterization. AAPS PharmSciTech 10(1):211\u2013219","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"3488_CR121","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1002\/jps.24044","volume":"103","author":"G Leyva-G\u00f3mez","year":"2014","unstructured":"Leyva-G\u00f3mez G, Gonz\u00e1lez-Trujano ME, L\u00f3pez-Ruiz E, Couraud PO, Wekslerg B, Romero I, Miller F, Delie F, All\u00e9mann E, Quintanar-Guerrero D (2014) Nanoparticle formulation improves the anticonvulsant effect of clonazepam on the pentylenetetrazole-induced seizures: behavior and electroencephalogram. J Pharm Sci 103(8):2509\u20132519","journal-title":"J Pharm Sci"},{"issue":"7","key":"3488_CR122","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1166\/jnn.2014.8722","volume":"14","author":"TH Tran","year":"2014","unstructured":"Tran TH, Ramasamy T, Cho HJ, Kim YI, Poudel BK, Choi HG, Yong CS, Kim JO (2014) Formulation and optimization of raloxifene-loaded solid lipid nanoparticles to enhance oral bioavailability. J Nanosci Nanotechnol 14(7):4820\u20134831","journal-title":"J Nanosci Nanotechnol"},{"key":"3488_CR123","first-page":"363","volume":"6","author":"S Eskandari","year":"2011","unstructured":"Eskandari S, Varshosaz J, Minaiyan M, Tabbakhian M (2011) Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model. Int J Nanomed 6:363\u2013371","journal-title":"Int J Nanomed"},{"issue":"2","key":"3488_CR124","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1517\/17425247.2014.945416","volume":"12","author":"T Alam","year":"2015","unstructured":"Alam T, Pandit J, Vohora D, Aqil M, Ali A, Sultana Y (2015) Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy. Expert Opin Drug Deliv 12(2):181\u2013194","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"3488_CR125","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1080\/03639045.2017.1386204","volume":"44","author":"A Motawea","year":"2018","unstructured":"Motawea A, Borg T, Abd El-Gawad AEH (2018) Topical phenytoin nanostructured lipid carriers: design and development. Drug Dev Indust Pharm 44(1):144\u2013157","journal-title":"Drug Dev Indust Pharm"},{"issue":"5","key":"3488_CR126","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.drudis.2018.01.005","volume":"23","author":"Y Feng","year":"2018","unstructured":"Feng Y, He H, Li F, Lu Y, Qi J, Wu W (2018) An update on the role of nanovehicles in nose-to-brain drug delivery. Drug Discovery Today 23(5):1079\u20131088","journal-title":"Drug Discovery Today"},{"key":"3488_CR127","doi-asserted-by":"crossref","unstructured":"Y Zheng, M Zheng, Z Ma, B Xin, R Guo, X Xu (2015) 8 - sugar fatty acid esters. In MU Ahmad, X Xu (Eds). Polar lipids. Elsevier, pp 215\u2013243.","DOI":"10.1016\/B978-1-63067-044-3.50012-1"},{"key":"3488_CR128","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejpb.2017.10.008","volume":"122","author":"P Mura","year":"2018","unstructured":"Mura P, Mennini N, Nativi C, Richichi B (2018) In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin. Eur J Pharm Biopharm 122:54\u201361","journal-title":"Eur J Pharm Biopharm"},{"key":"3488_CR129","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jddst.2015.05.002","volume":"32","author":"G Rassu","year":"2016","unstructured":"Rassu G, Soddu E, Cossu M, Gavini E, Giunchedi P, Dalpiaz A (2016) Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review. J Drug Delivery Sci Technol 32:77\u201387","journal-title":"J Drug Delivery Sci Technol"},{"key":"3488_CR130","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.carbpol.2018.07.054","volume":"199","author":"FNS Fachel","year":"2018","unstructured":"Fachel FNS, Medeiros-Neves B, Dal Pr\u00e1 M, Schuh RS, Veras KS, Bassani VL, Koester LS, Henriques AT, Braganhol E, Teixeira HF (2018) Box-Behnken design optimization of mucoadhesive chitosan-coated nanoemulsions for rosmarinic acid nasal delivery-In vitro studies. Carbohyd Polym 199:572\u2013582","journal-title":"Carbohyd Polym"},{"key":"3488_CR131","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","volume":"13","author":"AD Bangham","year":"1965","unstructured":"Bangham AD, Standish HM, Watkins JC (1965) Diffusion of univalentions across the lamellae of swollen phospholipids. J Mol Biol 13:238\u2013252","journal-title":"J Mol Biol"},{"issue":"3","key":"3488_CR132","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2174\/156720106777731019","volume":"3","author":"RM Mainardes","year":"2006","unstructured":"Mainardes RM, Urban MC, Cinto PO, Chaud MV, Evangelista RC, Gremi\u00e3o MP (2006) Liposomes and micro\/nanoparticles as colloidal carriers for nasal drug delivery. Curr Drug Deliv 3(3):275\u2013285","journal-title":"Curr Drug Deliv"},{"key":"3488_CR133","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/DDDT.S113171","volume":"10","author":"AK Al Asmari","year":"2016","unstructured":"Al Asmari AK, Ullah Z, Tariq M, Fatani A (2016) Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil. Drug Des Devel Ther 10:205\u2013215","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"3488_CR134","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2478\/v10007-008-0014-3","volume":"58","author":"K Arumugam","year":"2008","unstructured":"Arumugam K, Subramanian GS, Mallayasamy SR, Averineni RK, Reddy MS, Udupa N (2008) A study of rivastigmine liposomes for delivery into the brain through intranasal route. Acta Pharm (Zagreb, Croatia) 58(3):287\u2013297","journal-title":"Acta Pharm (Zagreb, Croatia)"},{"issue":"12","key":"3488_CR135","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1007\/s11095-015-1744-9","volume":"32","author":"X Zheng","year":"2015","unstructured":"Zheng X, Shao X, Zhang C, Tan Y, Liu Q, Wan X, Zhang Q, Xu S, Jiang X (2015) Intranasal H102 peptide-loaded liposomes for brain delivery to treat Alzheimer\u2019s disease. Pharm Res 32(12):3837\u20133849","journal-title":"Pharm Res"},{"key":"3488_CR136","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuroscience.2014.05.019","volume":"274","author":"MM Migliore","year":"2014","unstructured":"Migliore MM, Ortiz R, Dye S, Campbell RB, Amiji MM, Waszczak BL (2014) Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson\u2019s disease. Neuroscience 274:11\u201323","journal-title":"Neuroscience"},{"issue":"1","key":"3488_CR137","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nano.2007.12.001","volume":"4","author":"A Priprem","year":"2008","unstructured":"Priprem A, Watanatorn J, Sutthiparinyanont S, Phachonpai W, Muchimapura S (2008) Anxiety and cognitive effects of quercetin liposomes in rats. Nanomed Nanotechnol Biol Med 4(1):70\u201378","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"3488_CR138","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jconrel.2016.01.017","volume":"224","author":"YZ Zhao","year":"2016","unstructured":"Zhao YZ, Lin M, Lin Q, Yang W, Yu XC, Tian FR, Mao KL, Yang JJ, Lu CT, Wong HL (2016) Intranasal delivery of bFGF with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model. J Control Release 224:165\u2013175","journal-title":"J Control Release"},{"issue":"4","key":"3488_CR139","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3109\/10717544.2015.1120364","volume":"23","author":"P Upadhyay","year":"2016","unstructured":"Upadhyay P, Trivedi J, Pundarikakshudu K, Sheth N (2016) Comparative study between simple and optimized liposomal dispersion of quetiapine fumarate for diffusion through nasal route. Drug Delivery 23(4):1214\u20131221","journal-title":"Drug Delivery"},{"issue":"4","key":"3488_CR140","doi-asserted-by":"publisher","first-page":"482","DOI":"10.2174\/1567201812666150224114751","volume":"13","author":"AS Duttagupta","year":"2016","unstructured":"Duttagupta AS, Chaudhary HM, Jadhav KR, Kadam VJ (2016) Cubosomes: innovative nanostructures for drug delivery. Curr Drug Deliv 13(4):482\u2013493","journal-title":"Curr Drug Deliv"},{"issue":"2","key":"3488_CR141","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ejpb.2011.10.012","volume":"80","author":"H Wu","year":"2012","unstructured":"Wu H, Li J, Zhang Q, Yan X, Guo L, Gao X, Qiu M, Jiang X, Lai R, Chen H (2012) A novel small Odorranalectin-bearing cubosomes: preparation, brain delivery and pharmacodynamic study on amyloid-\u03b225\u201335-treated rats following intranasal administration. Eur Pharm Biopharm 80(2):368\u201378","journal-title":"Eur Pharm Biopharm"},{"key":"3488_CR142","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/08982104.2018.1552703","volume":"29","author":"R Patil","year":"2018","unstructured":"Patil R, Pawara DD, Gudewar CS, Tekade A (2018) Nanostructured cubosomes in an in situ nasal gel system: an alternative approach for the controlled delivery of donepezil HCl to brain. J Liposome Res 29:264\u2013273","journal-title":"J Liposome Res"},{"key":"3488_CR143","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejpb.2016.05.001","volume":"104","author":"H Azhari","year":"2016","unstructured":"Azhari H, Strauss M, Hook S, Boyd BJ, Rizwan SB (2016) Stabilising cubosomes with Tween 80 as a step towards targeting lipid nanocarriers to the blood-brain barrier. Eur J Pharm Biopharm 104:148\u201355","journal-title":"Eur J Pharm Biopharm"},{"issue":"10","key":"3488_CR144","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1080\/03639045.2017.1338721","volume":"43","author":"M Ahirrao","year":"2017","unstructured":"Ahirrao M, Shrotriya S (2017) In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting. Drug Dev Ind Pharm 43(10):1686\u20131693","journal-title":"Drug Dev Ind Pharm"},{"key":"3488_CR145","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejpb.2020.01.005","volume":"149","author":"MI Teixeira","year":"2020","unstructured":"Teixeira MI, Lopes CM, Amaral MH, Costa PC (2020) Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases. Eur J Pharm Biopharm 149:192\u2013217","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"3488_CR146","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ijpharm.2018.07.014","volume":"548","author":"N Youssef","year":"2018","unstructured":"Youssef N, Kassem AA, Farid RM, Ismail FA, El-Massik MAE, Boraie NA (2018) A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation. Int J Pharm 548(1):609\u2013624","journal-title":"Int J Pharm"},{"issue":"1","key":"3488_CR147","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3109\/10717544.2012.752421","volume":"20","author":"CV Pardeshi","year":"2013","unstructured":"Pardeshi CV, Rajput PV, Belgamwar VS, Tekade AR, Surana SJ (2013) Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach. Drug Delivery 20(1):47\u201356","journal-title":"Drug Delivery"},{"issue":"11","key":"3488_CR148","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1016\/j.fct.2011.08.006","volume":"49","author":"V Kakkar","year":"2011","unstructured":"Kakkar V, Kaur IP (2011) Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain. Food Chem Toxicol 49(11):2906\u20132913","journal-title":"Food Chem Toxicol"},{"issue":"7","key":"3488_CR149","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3109\/10717544.2014.880860","volume":"22","author":"R Bhatt","year":"2015","unstructured":"Bhatt R, Singh D, Prakash A, Mishra N (2015) Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington\u2019s disease. Drug Delivery 22(7):931\u2013939","journal-title":"Drug Delivery"},{"issue":"9","key":"3488_CR150","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jsps.2021.07.015","volume":"29","author":"M Elmowafy","year":"2021","unstructured":"Elmowafy M, Al-Sanea MM (2021) Nanostructured lipid carriers (NLCs) as drug delivery platform: advances in formulation and delivery strategies. Saudi Pharm J 29(9):999\u20131012","journal-title":"Saudi Pharm J"},{"issue":"3","key":"3488_CR151","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ejpb.2009.12.008","volume":"74","author":"CC Chen","year":"2010","unstructured":"Chen CC, Tsai TH, Huang ZR, Fang JY (2010) Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm 74(3):474\u201382","journal-title":"Eur J Pharm Biopharm"},{"key":"3488_CR152","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.2147\/IJN.S258791","volume":"15","author":"UA Fahmy","year":"2020","unstructured":"Fahmy UA, Ahmed OAA, Badr-Eldin SM, Aldawsari HM, Okbazghi SZ, Awan ZA, Bakhrebah MA, Alomary MN, Abdulaal WH, Medina C, Alhakamy NA (2020) Optimized nanostructured lipid carriers integrated into in situ nasal gel for enhancing brain delivery of flibanserin. Int J Nanomed 15:5253\u20135264","journal-title":"Int J Nanomed"},{"issue":"2","key":"3488_CR153","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/pharmaceutics11020084","volume":"11","author":"MC Bonferoni","year":"2019","unstructured":"Bonferoni MC, Rossi S, Sandri G, Ferrari F, Gavini E, Rassu G, Giunchedi P (2019) Nanoemulsions for \u201cnose-to-brain\u201d drug delivery. Pharmaceutics 11(2):84","journal-title":"Pharmaceutics"},{"issue":"6","key":"3488_CR154","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1039\/C2SM06903B","volume":"8","author":"DJ McClements","year":"2012","unstructured":"McClements DJ (2012) Nanoemulsions versus microemulsions: terminology, differences, and similarities. Soft Matter 8(6):1719\u20131729","journal-title":"Soft Matter"},{"issue":"5","key":"3488_CR155","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1089\/rej.2017.2035","volume":"21","author":"S Kumar","year":"2018","unstructured":"Kumar S, Dang S, Nigam K, Ali J, Baboota S (2018) Selegiline nanoformulation in attenuation of oxidative stress and upregulation of dopamine in the brain for the treatment of Parkinson\u2019s disease. Rejuvenation Res 21(5):464\u2013476","journal-title":"Rejuvenation Res"},{"issue":"7","key":"3488_CR156","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3109\/10717544.2013.878857","volume":"22","author":"BM Shah","year":"2015","unstructured":"Shah BM, Misra M, Shishoo CJ, Padh H (2015) Nose to brain microemulsion-based drug delivery system of rivastigmine: formulation and ex-vivo characterization. Drug Delivery 22(7):918\u2013930","journal-title":"Drug Delivery"},{"key":"3488_CR157","doi-asserted-by":"publisher","first-page":"101661","DOI":"10.1016\/j.jddst.2020.101661","volume":"57","author":"D Khunt","year":"2020","unstructured":"Khunt D, Polaka S, Shrivas M, Misra M (2020) Biodistribution and amyloid beta induced cell line toxicity study of intranasal Rivastigmine microemulsion enriched with fish oil and butter oil. J Drug Delivery Sci Technol 57:101661","journal-title":"J Drug Delivery Sci Technol"},{"issue":"1","key":"3488_CR158","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/1871527317666180104122347","volume":"17","author":"LC Espinoza","year":"2018","unstructured":"Espinoza LC, Vacacela M, Clares B, Garcia ML, Fabrega MJ, Calpena AC (2018) Development of a nasal donepezil-loaded microemulsion for the treatment of Alzheimer\u2019s disease: in vitro and ex vivo characterization. CNS Neurol Disord Drug Targets 17(1):43\u201353","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"8","key":"3488_CR159","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3109\/03639045.2015.1135936","volume":"42","author":"S Mandal","year":"2016","unstructured":"Mandal S, Mandal SD, Chuttani K, Sawant KK, Subudhi BB (2016) Design and evaluation of mucoadhesive microemulsion for neuroprotective effect of ibuprofen following intranasal route in the MPTP mice model. Drug Dev Ind Pharm 42(8):1340\u20131350","journal-title":"Drug Dev Ind Pharm"},{"key":"3488_CR160","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejps.2018.07.003","volume":"122","author":"E Pallagi","year":"2018","unstructured":"Pallagi E, Ismail R, Pa\u00e1l TL, Cs\u00f3ka I (2018) Initial risk assessment as part of the quality by design in peptide drug containing formulation development. Eur J Pharm Sci Pharm 122:160\u2013169","journal-title":"Eur J Pharm Sci Pharm"},{"issue":"8","key":"3488_CR161","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1021\/acs.molpharmaceut.1c00366","volume":"18","author":"AR Clementino","year":"2021","unstructured":"Clementino AR, Pellegrini G, Banella S, Colombo G, Cant\u00f9 L, Sonvico F, Del Favero E (2021) Structure and fate of nanoparticles designed for the nasal delivery of poorly soluble drugs. Mol Pharm 18(8):3132\u20133146","journal-title":"Mol Pharm"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-021-03488-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-021-03488-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-021-03488-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T13:09:56Z","timestamp":1675948196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-021-03488-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,20]]},"references-count":161,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["3488"],"URL":"https:\/\/doi.org\/10.1007\/s11064-021-03488-7","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,20]]},"assertion":[{"value":"25 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}